Figure 3.
Reverse cumulative distribution function (A, B) and vaccine effect (C) on the mean number of new genotypic infections in the per-protocol set between months 2·5–14·0 for R012-14 plus R012-20 and Fx012-14 vs the control regimen and between months 7·5–19·0 for Fx017-20 vs the control regimen